Glyburide And Metformin Hydrochloride Tablet
Product Images NDC 65841-825

5 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Glyburide And Metformin Hydrochloride (NDC 65841-825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Bbe22462 20b4 4cef A224 B00781a17922 01)

Image (Bbe22462 20b4 4cef A224 B00781a17922 01)
Chemical structure diagram of glyburide, one of the active ingredients in glyburide and metformin hydrochloride tablets. The diagram shows the molecular structure with labeled rings and functional groups.*
FDA Label Image

Image (Bbe22462 20b4 4cef A224 B00781a17922 02)

Image (Bbe22462 20b4 4cef A224 B00781a17922 02)
Chemical structure of metformin hydrochloride, showing its molecular arrangement with nitrogen, carbon, hydrogen atoms, and the hydrochloride component.*
FDA Label Image

Figure (Bbe22462 20b4 4cef A224 B00781a17922 03)

Figure (Bbe22462 20b4 4cef A224 B00781a17922 03)
Label for Glyburide and Metformin Hydrochloride Tablets, USP, 1.25 mg/250 mg strength, oral tablets. The label shows the NexGenerics brand and NDC 65841-824-01. It includes storage instructions, dispensing requirements, and manufacturer information for Cadila Healthcare Ltd., Baddi, India. The package contains 100 tablets for prescription use only.*
FDA Label Image

Figure (Bbe22462 20b4 4cef A224 B00781a17922 04)

Figure (Bbe22462 20b4 4cef A224 B00781a17922 04)
Label for Glyburide and Metformin Hydrochloride Tablets, USP, 2.5 mg/500 mg oral tablets by Zydus Lifesciences Limited. The label indicates a package of 100 tablets, prescription only, with instructions for pharmacists and storage details. Manufactured by Cadila Healthcare Ltd., Baddi, India.*
FDA Label Image

Figure (Bbe22462 20b4 4cef A224 B00781a17922 05)

Figure (Bbe22462 20b4 4cef A224 B00781a17922 05)
Label for Glyburide and Metformin Hydrochloride Tablets, USP 5 mg/500 mg, an oral tablet for human prescription use. The label shows the product name and strength prominently, with 100 tablets per container. It includes directions for pharmacists to dispense the patient information separately and storage instructions. The product is manufactured by Cadila Healthcare Ltd., Baddi, India, and labeled by Zydus Lifesciences Limited under the ZyGenerics brand.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.